Sign in

Marco Proietti MD PhD

@mproiettimd.bsky.social
126 followers 219 following 1 posts

Associate Professor of Internal and Geriatric Medicine Clinician, Scientist, Music & Arts Lover

PostsRepliesMedia
Reposted by Marco Proietti MD PhD
Liverpool Centre for Cardiovascular Science (LCCS) @liverpoolccs.bsky.social · 24/11/2024
Hello from LCCS at University of Liverpool, Liverpool John Moores University, Liverpool Heart & Chest Hospital and Liverpool Health Partners. We're expanding our reach here on Bluesky. 👇 Our mission: Tackling cardiac disease and helping people live longer, healthier lives #teamLCCS #collaboration
073
Reposted by Marco Proietti MD PhD
Liverpool Centre for Cardiovascular Science (LCCS) @liverpoolccs.bsky.social · 02/12/2024
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation #multimorbidity #Afib bmcmedicine.biomedcentral.com/articles/10....
bmcmedicine.biomedcentral.com
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries - BMC Medicine
Background In patients with atrial fibrillation (AF), the impact of peripheral artery disease (PAD) on oral anticoagulant (OAC) therapy use and the risk of outcomes remains unclear. Objective To analy...
021
Reposted by Marco Proietti MD PhD
Giulio Francesco Romiti @giuliofromiti.bsky.social · 30/11/2024
ESC Heart & Stroke 2024 has just ended - two days of great talks and discussion on heart-brain interactions. 📌 Get ready for the 2025 edition - coming to Italy! 🇮🇹 Save the date: 🗓️ 15-16 November 2025, Milan 🇮🇹 More info: esc365.escardio.org/event/1888
052
Reposted by Marco Proietti MD PhD
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 30/11/2024
💊 Direct Oral Anticoagulants: a quick primer on when to use ✅ and when to avoid ❌ Read on TH 👉 www.thieme-connect.com/products/ejo... #HemSky #CardioSky
163
Reposted by Marco Proietti MD PhD
Henry Han @hancardiomd.bsky.social · 29/11/2024
#ArtificialIntelligence and digital tools for design and execution of CV clinical trials The landscape of #AI in clinical trial planning academic.oup.com/eurheartj/ad... #CardioEd #CardioSky @drmarthagulati.bsky.social @joyywu.bsky.social @arghavansallesmd.bsky.social @cardioobdoc.bsky.social
0124
Reposted by Marco Proietti MD PhD
Jason Andrade @drjasonandrade.bsky.social · 18/11/2024
Congrats to Rajeev Pathak, @prashsanders.bsky.social and team on the ARREST-AF RCT. Incredibly informative data - adjective comprehensive risk factor optimisation significantly improved post ablation AF freedom. We now have RCT evidence supporting RFM as a foundation and pillar of AF management.
0158
Reposted by Marco Proietti MD PhD
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 27/11/2024
🌟 We’re on Bluesky! 🌟 Follow us for latest #thrombosis, #haemostasis, and #VascularBiology research ! #MedSky #HemeSky #Thrombosis #Hemostasis #Hematology #TH
1114
Reposted by Marco Proietti MD PhD
Giulio Francesco Romiti @giuliofromiti.bsky.social · 28/11/2024
Hello Bluesky from Athens 🇬🇷 where ESC Heart and Stroke 2024 is taking place! The 7th Annual Conference of the ESC Council on Stroke ⤵️ esc365.escardio.org/event/1665 #Medsky #Cardiosky #Strokesky
0103